• Je něco špatně v tomto záznamu ?

Blood-fetus penetration of pralidoxime

Shreesh Ojha, Syed M. Nurulain, S. Dhanasekeran, Mohammad Shafiullah, Abdu Adem, Charu Sharma, Kamil Kuča, Huba Kalasz

. 2016 ; 85 (2) : 63-68.

Jazyk angličtina Země Česko

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16026616

Pralidoxime (2-PAM) is a monopyridinium aldoxime-type compound of acetylcholinesterase reactivators. 2-PAM was introduced about five decades ago for the treatment of organophosphorus poisoning in order to reactivate inhibited acetylcholinesterase. The application of organophosphorus compounds is varied, including warfare agents, insecticides and pesticides in agriculture, the chemical industry, etc. The exposure is not limited to certain groups of humans: rather everyone can be affected, including pregnant women, and consequently fetuses as well. The present study was aimed to determine the 2-PAM concentration in the plasma of pregnant mice, assuming a different physiological condition than non-pregnant ones. Blood-placenta penetration of 2-PAM was also investigated. 2-PAM was intraperitoneally injected into mice on gestational day 18 and mother blood was collected following 5, 15, 30 and 90 minutes. Four fetuses along with their placentas were collected at every time point. HPLC-UV method was employed to determine the 2-PAM concentrations. The result showed higher levels of 2-PAM at 15 minutes (tmax) in the plasma of pregnant mice compared to non-pregnant ones. Moreover, 2-PAM copiously reached the placenta, which is a store house of nutrients for the fetus. A higher concentration of 2-PAM was found in the brain of fetuses in comparison to that of the mothers’. Our study concludes that 2-PAM crosses the placenta barrier and reaches the brain of the fetus in a more ample quantity than that in the mother’s brain. The results provide an insight into a special condition of pregnancy when antidotal application of the acetylcholinesterase reactivator 2-PAM in organophosphorus poisoning results in 2-PAM exposure in the fetus.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc16026616
003      
CZ-PrNML
005      
20161129161537.0
007      
ta
008      
160926s2016 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.31482/mmsl.2016.012 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Ojha, Shreesh $u Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United rab Emirates
245    10
$a Blood-fetus penetration of pralidoxime / $c Shreesh Ojha, Syed M. Nurulain, S. Dhanasekeran, Mohammad Shafiullah, Abdu Adem, Charu Sharma, Kamil Kuča, Huba Kalasz
504    __
$a Literatura
520    9_
$a Pralidoxime (2-PAM) is a monopyridinium aldoxime-type compound of acetylcholinesterase reactivators. 2-PAM was introduced about five decades ago for the treatment of organophosphorus poisoning in order to reactivate inhibited acetylcholinesterase. The application of organophosphorus compounds is varied, including warfare agents, insecticides and pesticides in agriculture, the chemical industry, etc. The exposure is not limited to certain groups of humans: rather everyone can be affected, including pregnant women, and consequently fetuses as well. The present study was aimed to determine the 2-PAM concentration in the plasma of pregnant mice, assuming a different physiological condition than non-pregnant ones. Blood-placenta penetration of 2-PAM was also investigated. 2-PAM was intraperitoneally injected into mice on gestational day 18 and mother blood was collected following 5, 15, 30 and 90 minutes. Four fetuses along with their placentas were collected at every time point. HPLC-UV method was employed to determine the 2-PAM concentrations. The result showed higher levels of 2-PAM at 15 minutes (tmax) in the plasma of pregnant mice compared to non-pregnant ones. Moreover, 2-PAM copiously reached the placenta, which is a store house of nutrients for the fetus. A higher concentration of 2-PAM was found in the brain of fetuses in comparison to that of the mothers’. Our study concludes that 2-PAM crosses the placenta barrier and reaches the brain of the fetus in a more ample quantity than that in the mother’s brain. The results provide an insight into a special condition of pregnancy when antidotal application of the acetylcholinesterase reactivator 2-PAM in organophosphorus poisoning results in 2-PAM exposure in the fetus.
650    12
$a pralidoximové sloučeniny $x farmakologie $x metabolismus $x terapeutické užití $7 D011220
650    _2
$a organofosforové sloučeniny $x škodlivé účinky $7 D009943
650    _2
$a reaktivátory cholinesterázy $x farmakokinetika $x metabolismus $x terapeutické užití $7 D002801
650    _2
$a modely u zvířat $7 D023421
650    _2
$a maternofetální výměna látek $7 D008431
650    _2
$a antidota $x farmakologie $x metabolismus $x terapeutické užití $7 D000931
650    _2
$a vývoj plodu $x účinky léků $7 D047109
650    _2
$a mozek $x růst a vývoj $x účinky léků $7 D001921
650    _2
$a myši $7 D051379
650    _2
$a těhotenství $7 D011247
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Nurulain, Syed M. $u Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United rab Emirates; COMSATS Institute of Information Technology, Islamabad, Pakistan
700    1_
$a Dhanasekeran, S. $u Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United rab Emirates
700    1_
$a Shafiullah, Mohammad $u Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United rab Emirates
700    1_
$a Adem, Abdu $u Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United rab Emirates $7 gn_A_00001725
700    1_
$a Sharma, Charu $u Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
700    1_
$a Kuča, Kamil, $d 1978- $7 xx0041831 $u Centre of Advanced Studies, Faculty of Military Health Science, Hradec Kralove, Czech Republic
700    1_
$a Kalasz, Huba $u Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United rab Emirates; Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Budapest, Hungary
773    0_
$t Vojenské zdravotnické listy $x 0372-7025 $g Roč. 85, č. 2 (2016), s. 63-68 $w MED00011116
856    41
$u http://www.mmsl.cz/archive $y domovská stránka časopisu
910    __
$a ABA008 $b A 3 $c 1073 $y 4 $z 0
990    __
$a 20150120115154 $b ABA008
991    __
$a 20161129161537 $b ABA008
999    __
$a ok $b bmc $g 1164413 $s 951236
BAS    __
$a 3
BMC    __
$a 2016 $b 85 $c 2 $d 63-68 $i 0372-7025 $m Vojenské zdravotnické listy $x MED00011116
LZP    __
$c NLK125 $d 20161129 $a NLK 2016-32/dk

Najít záznam

Citační ukazatele

Možnosti archivace